Josef Finsterer, MD, PhD*, Marlies Frank, MD. “Evidence Level for Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Respectively Sodium Glucose Co-Transporter-2 Inhibitors for Mitochondrial Diabetes Is Low”. Innovative Journal of Medical and Health Sciences, vol. 10, no. 06, June 2020, pp. 959-60, https://innovativejournal.in/index.php/ijmhs/article/view/2988.